Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector ...

Xeris Biopharma is showing strong growth and improving EBITDA, especially driven by its blockbuster drug Recorlev. Learn why ...

AbbVie Inc. (NYSE:ABBV) is included among the 12 Best Stocks to Buy for the Long Term. On January 27, Citi modestly cut its ...

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical ...

Biopharma SHAKTI stocks surge post-2026 budget, highlighting India's shift towards biologics and enhanced clinical trial ...

Simtra BioPharma Solutions, a CDMO, formed a five-year strategic alliance with the life science business of Germany-based Merck KGaA, which operates as MilliporeSigma in the U.S. and Canada. The ...

GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026 Phase 1 protocol allows multiple solid tumor ...

British biopharma major GSK to acquire US-based biopharma company RAPT Therapeutics via a $2.2 billion deal. Here's what investors need to know about the update, which is expected to close by first ...

Key Milestone Builds Toward Doubling Patent Portfolio to Over 200 Worldwide - Positioning Propanc as a Long-Term Leader in Metastatic Cancer Prevention ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

A well-defined CAPA system is essential for any biopharmaceutical company to drive quality improvements across the organization. Hence, it is imperative for biopharmaceutical organizations to measure ...